Efficacy and safety of levetiracetam in patients with glioma: A clinical prospective study

Archives of Neurology

Volumn 67, Issue 3, 2010, Pages 343-346

  Rosati, Anna ^a   Buttolo, Luciano ^b   Stefini, Roberto ^b   Todeschini, Alice ^b   Cenzato, Marco ^b   Padovani, Alessandro ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; OXCARBAZEPINE; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ADULT; AGED; ARTICLE; ASTROCYTOMA; CLINICAL TRIAL; COMPLEX PARTIAL SEIZURE; DIARRHEA; DISEASE DURATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; GLIOBLASTOMA; GLIOMA; GLIOSARCOMA; GRAND MAL SEIZURE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; SEIZURE; SIMPLE PARTIAL SEIZURE; THOUGHT DISORDER; VISUAL HALLUCINATION;

ADULT; AGED; ANTICONVULSANTS; BRAIN NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; PIRACETAM; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 77749338165     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.335     Document Type: Article

References (26)

1. Cascino GD. Epilepsy and brain tumors. Epilepsia. 1990;31(suppl 3):S37-S44.
2. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993;34(3):453-468.
3. Morris HH, Estes ML. Brain tumors and chronic epilepsy. In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practice. Philadelphia, PA: Lea & Febiger; 1993:659-666.
4. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumors in adults. Lancet. 2003;361(9354):323-331.
5. Annegers JF, Hauser WA, Lee JR, Rocca W. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia. 1995;36(4):327-333.
6. Kivistö KT, Kroemer HK, Eichelbaum M. The role of human cytochrome P450 enzymes in the metabolism and anticancer agents: implications for drug interactions. Br J Clin Pharmacol. 1995;40(6):523-530.
7. Vecht CJ, Wagner GL, Wilms EB. Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol. 2003;2(7):404-409.
8. Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther. 2000;85(2):77-85.
9. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981;22(4):489-501.
10. Kleihues P, Burger PC, Aldape KD, et al. World Health Organization Classification of Tumours of Central Nervous System. Lyon, France: International Agency for Research on Cancer; 2007:33-49.
11. Stupp R, Mason WP, van den Bent MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10):987-996.
12. Siomin V, Angelov L, Li L, Vogelbaum MA. Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors. J Neurooncol. 2005;74(2):211-215.
13. Glantz MJ, Cole BF, Friedberg MH, et al. A randomized, blinded, placebocontrolled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumours. Neurology. 1996;46(4):985-991.
14. Glantz MJ, Cole BF, Forsyth PA, et al; Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumours. Neurology. 2000; 54(10):1886-1893.
15. Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc. 2004; 79(12):1489-1494.
16. Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B. The course of seizure disorders in patients with malignant gliomas. Arch Neurol. 1995; 52(7):717-724.
17. Pace A, Bove L, Innocenti P, et al. Epilepsy and gliomas: incidence and treatment in 119 patients. J Exp Clin Cancer Res. 1998;17(4):479-482.
18. Wagner GL, Wilms EB, Van Donselaar CA, Vecht C. Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure. 2003;12(8):585-586.
19. Wick W, Menn O, Meisner C, et al. Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie. 2005;28(8-9):391-396.
20. Newton HB, Goldlust SA, Pearl D. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol. 2006;78(1): 99-102.
21. Liigant A, Haldre S, Oun A, et al. Seizure disorders in patients with brain tumors. Eur Neurol. 2001;45(1):46-51.
22. van Breemen MS, Rijsman RM, Taphoorn MJ, Walchenbach R, Zwinkels H, Vecht CJ. Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol. 2009;256(9):1519-1526.
23. Rosati A, Tomassini A, Pollo B, et al. Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neurooncol. 2009;93(3):395-400.
24. van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours. Lancet Neurol. 2007;6(5):421-430.
25. Hildebrand J, Lecaille C, Perennes J, Delattre JY. Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology. 2005;65(2): 212-215.
26. Haghikia A, Ladage K, Hinkerohe D, et al. Implications of antiinflammatory properties of the anticonvulsant drug levetiracetam in astrocytes. J Neurosci Res. 2008; 86(8):1781-1788.